Skip to content

Protalix BioTherapeutics, Inc.: filings

Every Protalix BioTherapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 64 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026391140001104659-26-094444
10-Q2026-05-13fiscal Q1 202638770001104659-26-059756
10-K2026-03-18fiscal FY 2025461220001104659-26-029858
10-Q2025-11-13fiscal Q3 2025411160001104659-25-110824
10-Q2025-08-14fiscal Q2 2025381070001558370-25-011471
10-Q2025-05-09fiscal Q1 202537750001558370-25-007063
10-K2025-03-17fiscal FY 2024461210001558370-25-003039
10-Q2024-11-14fiscal Q3 2024401140001558370-24-015612
10-Q2024-08-14fiscal Q2 2024411120001558370-24-012134
10-Q2024-05-10fiscal Q1 202441800001558370-24-007695
10-K2024-03-14fiscal FY 2023471220001558370-24-003161
10-Q2023-11-06fiscal Q3 2023401090001558370-23-017664
10-Q2023-08-07fiscal Q2 2023401090001558370-23-013483
10-Q2023-05-04fiscal Q1 202336730001558370-23-008132
10-K2023-02-27fiscal FY 2022451160001558370-23-002102
10-Q2022-11-14fiscal Q3 202234960001558370-22-017554
10-Q2022-08-15fiscal Q2 202234960001558370-22-013560
10-Q2022-05-16fiscal Q1 202233670001558370-22-008847
10-K2022-03-31fiscal FY 2021431080001558370-22-004823
10-Q2021-11-15fiscal Q3 202133920001558370-21-015862
10-Q2021-08-16fiscal Q2 202128750001558370-21-011752
10-Q2021-05-14fiscal Q1 202128590001558370-21-007157
10-K2021-03-30fiscal FY 202037920001558370-21-003681
10-Q2020-10-29fiscal Q3 202027730001558370-20-011974
10-Q2020-08-10fiscal Q2 202027730001104659-20-092375
10-Q2020-06-01fiscal Q1 202027570001104659-20-067982
10-K2020-03-12fiscal FY 2019371100001104659-20-032540
10-Q2019-11-07fiscal Q3 201930770001104659-19-060804
10-Q2019-08-08fiscal Q2 201930770001144204-19-038552
10-Q2019-05-06fiscal Q1 201928590001144204-19-023895
10-K2019-03-18fiscal FY 201833840001144204-19-014464
10-Q2019-03-18fiscal Q3 201827680001144204-19-014455
10-Q2019-03-18fiscal Q2 201831840001144204-19-014453
10-Q2019-03-18fiscal Q1 201827550001144204-19-014450
10-Q2018-11-07fiscal Q3 201827740001144204-18-057990
10-Q2018-08-09fiscal Q2 201831900001144204-18-043286
10-Q2018-05-09fiscal Q1 201827570001144204-18-026625
10-K2018-03-06fiscal FY 201734890001144204-18-013053
10-Q2017-11-08fiscal Q3 201726720001144204-17-057290
10-Q2017-08-09fiscal Q2 201729860001144204-17-041693
10-Q2017-05-10fiscal Q1 201725540001144204-17-026034
10-K2017-03-16fiscal FY 201632830001144204-17-015083
10-Q2016-11-09fiscal Q3 201625700001144204-16-132819
10-Q2016-08-08fiscal Q2 201625700001144204-16-117287
10-Q2016-05-09fiscal Q1 201624520001144204-16-099933
10-K2016-03-08fiscal FY 201532840001144204-16-086642
10-Q2015-11-09fiscal Q3 201522620001144204-15-063825
10-Q2015-08-10fiscal Q2 201523660001144204-15-047801
10-Q2015-05-07fiscal Q1 201523500001144204-15-028431
10-K2015-03-12fiscal FY 201430750001144204-15-015672
10-Q2014-11-10fiscal Q3 201421620001144204-14-066530
10-Q2014-08-07fiscal Q2 201421620001144204-14-047741
10-Q2014-05-08fiscal Q1 201421460001144204-14-028653
10-K2014-03-13fiscal FY 201328710001144204-14-015468
10-Q2013-11-07fiscal Q3 201325700001144204-13-059668
10-Q2013-08-08fiscal Q2 201328840001144204-13-043990
10-Q2013-05-09fiscal Q1 201323490001144204-13-027499
10-K2013-02-28fiscal FY 201229760001144204-13-012065
10-Q2012-11-07fiscal Q3 201224650001144204-12-060041
10-Q2012-08-03fiscal Q2 201228810001144204-12-042862
10-Q2012-05-09fiscal Q1 201224520001144204-12-027198
10-K2012-02-27fiscal FY 201126680001144204-12-011082
10-Q2011-11-07fiscal Q3 201124640001144204-11-061636
10-Q2011-08-08fiscal Q2 201124660001144204-11-044353

Inspect the source

Entity
Protalix BioTherapeutics, Inc. / CIK 0001006281
Captured
2026-09-20T05:12:00.706Z
SEC response SHA-256
5022eb9c9008f3ac21090b4bd34c0341e843ccbd807493dfa2a9e5fc19632a16

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001006281.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))